Across TCGA pan-cancer cohorts, UBE2V1P15 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated UBE2V1P15 data layer.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher UBE2V1P15 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2V1P15 expression acts as an unfavorable survival marker, although some lineages such as OV and ACC show a favorable association.
PAAD, LUSC, and BLCA are the cancer types where UBE2V1P15 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.